PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes-Reference-Cited by-同舟云学术

PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes

Published:2017-04-19 Issue:31 Volume:8 Page:51210-51223
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Yajuan¹²,Miao Jingjing³,Wu Haijun³,Tang Hao⁴,Kuang Jing⁴,Zhou Xiaoyi²,Peng Yi²,Hu Desheng²,Shi Dingbo⁵,Deng Wuguo⁵,Cao Xinyue⁶,Zhao Chong¹³,Xie Conghua¹

Affiliation:

1. Hubei Key Laboratory of Tumor Biological Behaviors, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China

2. Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, China

3. Department of Nasopharynx, Collaborative Innovation Center for Cancer Medical, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China

4. Department of Pathology, Hubei Cancer Hospital, Wuhan, China

5. Collaborative Innovation Center for Cancer Medical, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China

6. Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model;Biomedical Research and Therapy;2024-02-29

2. Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice;International Immunopharmacology;2023-08

3. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA–mRNA network mining and machine learning;Frontiers in Endocrinology;2023-07-19

4. Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children;Journal of Cancer Research and Clinical Oncology;2023-06-14

5. Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis;Oral Oncology;2023-01